Kate B. Hubbard, MSN, RN, OCN®, NPD-BCBest Practices | November 7, 2022
In response to more oral therapies, cancer centers are creating standardized oral oncolytic programs to improve patient care.
Read More
Leah LawrenceTreatment | November 1, 2022
Patients were prompted to input pain severity scores using a visual analog scale from 0-10 at multiple times during a day.
Teresa Hagan Thomas, PhD, RNBest Practices | October 31, 2022
The guidelines are based on a review of 227 articles that compared integrative therapies to a comparison group.
Leah LawrenceTreatment | October 5, 2022
Use of a short-course electric massage chair with standard of care helped reduce chemotherapy-induced nausea and vomiting.
Leah LawrenceTreatment | October 5, 2022
A recently published guideline offers suggested recommendations to support patient adherence to oral anticancer medications.
Leah LawrenceTreatment | September 27, 2022
Use of a 3-stage capacity-consent process provides time to show a patient’s capacity to consent to proposed cancer ...
Leah LawrenceTreatment | September 20, 2022
A new intervention could help restore normal functioning in the brains of chemotherapy patients through neurofeedback.
Leah LawrenceTreatment | September 10, 2022
A text message questionnaire identified patients with solid tumors who were not experiencing symptoms of ICI toxic effects.
Emily MenendezTreatment | August 29, 2022
Various vaccines and immunotherapies such as sipuleucel-T and BCG are important to consider in preventive cancer care.
Leah LawrenceTreatment | July 27, 2022
A multidisciplinary treatment-related adverse events management program resulted in improvement of related toxicities.
Cecilia BrownMyelofibrosis | July 21, 2022
Pacritinib was found to be more effective than best available treatment at reducing spleen volume in myelofibrosis patients.
Cecilia BrownMyelofibrosis | July 20, 2022
Adding navitoclax to ruxolitinib treatment in patients with persistent or progressive myelofibrosis led to durable splee
Cecilia BrownMyelofibrosis | July 19, 2022
Myelofibrosis patients treated with fludarabine and busulfan along with TBI saw reduction in graft failure.
Teresa Hagan Thomas, PhD, RNGI Cancer | July 15, 2022
The Australian study put men with prostate cancer receiving androgen deprivation therapy on an exercise program.
Leah LawrenceTreatment | July 14, 2022
Researchers evaluated whether outpatients suites could improve quality measures.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | July 14, 2022
The basics of PTCy after hematopoietic cell transplantation for GVHD prevention, plus, how nurses can explain PTCy to patient
Vanessa IraPatient Voice | July 12, 2022
Cancer patients participating in medical tourism should know how seeking care outside of the US could disrupt care plan.
Teresa Hagan Thomas, PhD, RNTreatment | July 12, 2022
One concern that keeps patients from enrolling in clinical trials is the belief that their quality of life will suffer.
Leah LawrenceTreatment | June 23, 2022
Extending the interval of port flushes to every 12 weeks did not increase the incidence of port-related adverse events.
Emily MenendezNews | June 16, 2022
Clinics also postponed or deferred radiation treatments and elective surgeries.